← FDA Drug Approvals (Drugs@FDA)

ANDA210445

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX INC · Approved 2019-08-16

Drug application

FDA Application #

ANDA210445

Application type

Abbreviated New Drug Application (Generic)

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

APOTEX INC

First approval

2019-08-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown